Granules India receives license from DRDO to manufacture and market 2-DG

2- Deoxy-D-Glucose has been granted permission by DCGI for emergency use of this drug as an adjunct therapy in moderate to severe Covid 19 patients.

from India Infoline News Service https://ift.tt/3BxGlgU